- Home
- SSKN vs ADXN Comparison
SSKN vs ADXN Comparison
Compare SSKN & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSKN
- ADXN
- Stock Information
- Founded
- SSKN 1989
- ADXN 2002
- Country
- SSKN United States
- ADXN Switzerland
- Employees
- SSKN N/A
- ADXN N/A
- Industry
- SSKN Medical/Dental Instruments
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- SSKN Health Care
- ADXN Health Care
- Exchange
- SSKN Nasdaq
- ADXN Nasdaq
- Market Cap
- SSKN 8.9M
- ADXN 8.0M
- IPO Year
- SSKN 2005
- ADXN N/A
- Fundamental
- Price
- SSKN $1.40
- ADXN $9.36
- Analyst Decision
- SSKN Strong Buy
- ADXN Strong Buy
- Analyst Count
- SSKN 1
- ADXN 1
- Target Price
- SSKN $6.00
- ADXN $30.00
- AVG Volume (30 Days)
- SSKN 2.9M
- ADXN 60.8K
- Earning Date
- SSKN 11-12-2025
- ADXN 09-01-2025
- Dividend Yield
- SSKN N/A
- ADXN N/A
- EPS Growth
- SSKN N/A
- ADXN N/A
- EPS
- SSKN N/A
- ADXN 0.10
- Revenue
- SSKN $32,848,000.00
- ADXN $278,508.00
- Revenue This Year
- SSKN N/A
- ADXN $86.57
- Revenue Next Year
- SSKN $9.70
- ADXN N/A
- P/E Ratio
- SSKN N/A
- ADXN $0.88
- Revenue Growth
- SSKN 0.36
- ADXN N/A
- 52 Week Low
- SSKN $1.38
- ADXN $6.51
- 52 Week High
- SSKN $3.86
- ADXN $12.05
- Technical
- Relative Strength Index (RSI)
- SSKN 37.68
- ADXN 53.53
- Support Level
- SSKN $1.52
- ADXN N/A
- Resistance Level
- SSKN $1.70
- ADXN $12.05
- Average True Range (ATR)
- SSKN 0.39
- ADXN 0.28
- MACD
- SSKN -0.05
- ADXN -0.14
- Stochastic Oscillator
- SSKN 0.81
- ADXN 77.68
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.